J L Robertson Selected Research

Interleukin-2 (IL2)

5/2001

CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J L Robertson Research Topics

Disease

3	Neoplasms (Cancer) 02/2011 - 01/2006
2	Glioma (Gliomas) 03/2014 - 02/2011
1	Brain Diseases (Brain Disorder) 02/2011
1	Intracranial Hypertension 02/2011
1	Soft Tissue Neoplasms 02/2011
1	Meningioma (Meningiomas) 09/2009
1	Hepatitis 05/2001
1	Body Weight (Weight, Body) 05/2001
1	Metaplasia 01/2001
1	Abscess 01/2001
1	Hyperplasia 01/2001

Drug/Important Bio-Agent (IBA)

1	Carboplatin (JM8)FDA LinkGeneric 03/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2014
1	Therapeutic UsesIBA 09/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009
1	EndostatinsIBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Interleukin-2 (IL2)IBA 05/2001
1	Concanavalin AIBA 05/2001
1	CytokinesIBA 05/2001
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2001
1	Fas Ligand Protein (Fas Ligand)IBA 05/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2001
1	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 01/2001
1	Heptachlor EpoxideIBA 01/2001
1	Keratins (Keratin)IBA 01/2001
1	oxychlordaneIBA 01/2001
1	Vitamin A (Retinol)FDA LinkGeneric 01/2001

Therapy/Procedure

1	Radiotherapy 02/2011
1	Therapeutics 02/2011